EP1025202A1 - Method for culturing microbiological samples in a gas pressure gradient - Google Patents

Method for culturing microbiological samples in a gas pressure gradient

Info

Publication number
EP1025202A1
EP1025202A1 EP98950130A EP98950130A EP1025202A1 EP 1025202 A1 EP1025202 A1 EP 1025202A1 EP 98950130 A EP98950130 A EP 98950130A EP 98950130 A EP98950130 A EP 98950130A EP 1025202 A1 EP1025202 A1 EP 1025202A1
Authority
EP
European Patent Office
Prior art keywords
sample
filter
culture
colonies
pressure gradient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98950130A
Other languages
German (de)
French (fr)
Inventor
Olli-Pekka Lehtonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aboatech Oy AB
Original Assignee
Aboatech Oy AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aboatech Oy AB filed Critical Aboatech Oy AB
Publication of EP1025202A1 publication Critical patent/EP1025202A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/005Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor after treatment of microbial biomass not covered by C12N1/02 - C12N1/08
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/02Membranes; Filters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M33/00Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
    • C12M33/04Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus by injection or suction, e.g. using pipettes, syringes, needles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/40Means for regulation, monitoring, measurement or control, e.g. flow regulation of pressure

Definitions

  • the present invention relates to a method for culturing microbiological samples.
  • the method comprises filtering a prepared sample and culturing the sample on the filter in the presence of a pressure gradient.
  • Culture is currently the basic method in clinical microbiological laboratories. Despite of the development of various techniques, especially the genetic engineering in the diagnosis of infectious diseases, clinical laboratories do need the culture methods also in the future. Culture is versatile for a wide spectrum of organisms being the only simple method to detect new and unexpected organisms. It is relatively cheap to perform and thus it has an established position in the diagnosis of the most common bacterial infections. Culture is also the only method to supply with live organisms for further reference and phenotypic testing of drug susceptibility. Environmental and food laboratories do also exploit the advantages of culture techniques.
  • Automated susceptibility testing systems are available. They, however, need a standardized inoculum, preferably from colonies grown on a solid medium.
  • the present invention provides a filter culture method which enables automated culturing of microbes.
  • the method is called "Bactexpress" method.
  • the method can be applied for various biological samples, e.g. body fluids, but also for water samples, or filterable food or environmental samples .
  • a sample is first prepared to be filterable, if appropriate, i.e. in the case of a biological sample eukaryotic cells present in said sample are lysed. Then the sample obtained is filtered using a microbiological filter, and the filter is flushed with a liquid nutrient medium, which remains on the other side of the filter.
  • the microbes which remain on the filter are made to grow on it as if they grew on an agar plate, by establishing a gas pressure gradient using appropriate gases or gas mixtures.
  • the medium should remain in contact with the filter. This can be accomplished e.g. by turning the filter around.
  • the pressure gradient is used to prevent the medium from bleeding to the side of the filter where the microbes have been trapped. It is easy to change nutrient media and the gas mixtures during incubation.
  • the method is suitable for automation as the culture method can be carried out using liquid flows, for which suitable technologies exist.
  • the culture method of the invention uses bacteriological filters (e.g. cellulose acetate) with pore sizes of 0.22 to 1.0 ⁇ m. Such filters are manufactured by e.g. Millipore. Most of the clinically relevant samples (blood, urine, ascites, pus, cerebrospinal fluid, synovial fluid) can be prepared for filtration by lysing the eukaryotic cells present therein. E.g. Zierdt (1982) has described a lysis process which can be used in the present method. Filtration of biological samples is described in various publications (e.g. Wallis & Melnick, 1985, Longoria et al . , 1987 and Bernhardt et al .
  • any such filtration system can be used in the present method.
  • the filter is flushed with a liquid medium to remove growth inhibitors possibly present in a clinical sample. Then, a further amount of liquid medium is added and filtered until to the other side of the filter. After filtration the filter is turned around, and a gas pressure gradient is established leading a gas or a gas mixture to the filter from below upwards, thereby constructing a solid-liquid interface.
  • l pilot scale arrangement for this system is illustrated. This setup gives a growth environment which results in visible colonies similarly as on an agar plate.
  • a similar type of idea of combining liquid and solid media was disclosed decades ago (Kanz, 1951) but without the filtration procedure for inoculation of the sample.
  • Kanz used cellophane which is quite inappropriate for filtration. Contamination of the liquid medium is easy to avoid because the liquid flows in one direction only through the filter. The liquid medium can easily be changed, even during incubation, if necessary. Different gas mixtures can be used for different atmospheric requirements of the microbes.
  • the principle of the inventive method is illustrated in the appended Figure 2.
  • the now presented configuration would enable automation because control of the culture process is easy by regulating the flow of the liquid nutrient medium. Using solid culture media would necessitate very cumbersome robotics.
  • the liquid flow serves for inoculation of the sample, con- struction of the "solid" culture medium as well as disinfection and removal of infectious material.
  • Video technology could be used for the subsequent surveillance of the growth of the colonies, and gas chromatography or sequence analysis of ribosomal DNA would be useful for further auto- matic identification of the cultures.
  • Fig. 2 The liquid nutrient broth and the test sample are first filtered through the filter; the bacteria remain on the side B. The filter is then turned around, and the nutrient broth on the side A acts as growth medium. Diffu- sion of the nutrient broth to side B and prevention of excessive moisture by a pressure gradient (0.01 to 0.5 bar) enable growth of visible and dispersed colonies as on agar plates.
  • the experiments were carried out using blood culture samples .
  • the blood samples were filterable in the given circumstances (see Wallis and Melnick, 1985) when detergents were added to a commercially available sample tube (IsolatorTM).
  • the microbes tested in pure cultures Escherichia coll, Enterococcus faecalis , Haemophilus influ- enzae. Streptococcus pne ⁇ moniae , Streptococcus miller 1, Streptococcus agalactiae, Candida albicans, Pseudomonas aeruginosa, Staphylococcus epidermidis, Pasteurella multo- cida, Bacteroides fragili ⁇
  • Example 1 Comparative tests - present system versus agar plate cultivation
  • Comparative tests using the present filter culture method and on the other hand transferring the filter onto a conventional agar plate were carried out with the above listed microbes.
  • the agar plate method with filter is currently used e.g. in food laboratories.
  • the parameters measured were 1) number of the colonies, 2) size of the colonies, and 3 ) existence of separate colonies.
  • the variables were a) composition of the nutrient medium, b) incubation time and c) different types of membrane filters.
  • the influence of antibiotics on the filters as well as changing of the nutrient medium during the incubation ' were also studied.
  • BHI Brain Heart Infusion (Difco)
  • FBS Fetal Bovine Serum 5% (Finnzymes Oy)
  • BLOOD heated sheep blood
  • 5% NAD a growth factor in blood (7.5 ⁇ g/ml )
  • HEMIN a growth factor in blood (7.5 ⁇ g/ml )
  • Example 2 Comparative tests with Escherichia coli and Enterococcus faecalis
  • Example 3 Seeking the optimum conditions for Streptococcus agalactiae
  • the optima of Bactexpress-method for a clinical strain of Streptococcus agalactiae were studied by varying the pressure and concentration of fetal bovine serum (FBS) in tryptic soya broth. The yield of colonies was compared to the yield of colonies on tryptic soya agar with 0.5 per cent FBS. The mean diameter of the colonies was measured from 10 individual colonies on filter. The number of colonies not confluent to adjacent colonies was counted and expressed as the percentage of the total number of colonies. Each combination of pressure and serum concentration was studied in five parallel filters. The results are shown in Tables 3, 4 and 5.
  • FBS fetal bovine serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to a method for culturing microbiological samples. The method comprises filtering a prepared sample and culturing the sample on the filter in the presence of a pressure gradient.

Description

METHOD FOR CULTURING MICROBIOLOGICAL SAMPLES IN A GAS PRESSURE GRADIENT
Field of the invention
The present invention relates to a method for culturing microbiological samples. The method comprises filtering a prepared sample and culturing the sample on the filter in the presence of a pressure gradient.
Background of the invention
Culture is currently the basic method in clinical microbiological laboratories. Despite of the development of various techniques, especially the genetic engineering in the diagnosis of infectious diseases, clinical laboratories do need the culture methods also in the future. Culture is versatile for a wide spectrum of organisms being the only simple method to detect new and unexpected organisms. It is relatively cheap to perform and thus it has an established position in the diagnosis of the most common bacterial infections. Culture is also the only method to supply with live organisms for further reference and phenotypic testing of drug susceptibility. Environmental and food laboratories do also exploit the advantages of culture techniques.
Culture is said to be slow. However, a bacterial mass large enough for modern susceptibility testing and identification can be grown in less than 10 hours. Most of the clinically relevant bacteria yield visible colonies in 16 hours. Iden- tification by antigen detection or gene hybridization can be performed in 1 to 2 hours and modern susceptibility testing for rapidly growing bacteria can be done in 4 to 6 hours. Thus, the overall analysis time for rapidly growing bacteria is less than 24 hours. Considering assisting in the choice of antimicrobials this is quite a reasonable delivery time. However, in current microbiological laboratories the total delivery time for a sample submitted for culture tends to be substantially longer. In addition to transport of the sample and reporting of the results, there are long time periods when the sample is not in the process. Samples wait for culturing, cultures wait for interpretation, subcultures wait for identification, and susceptibility tests wait for reading. There are automatic apparatuses available for the follow-up of growth, identification and suscepti- bility testing (Jδrgensen, 1987). However, optimal use of these would necessarily require a laboratory with three working shifts because transfer of the material from one automate to another is still purely manual.
It has been pointed out that clinical bacteriology has only a limited impact on clinical decision-making ( Campo & Mylotte, 1988; Rintala et al . , 1991; Lehtonen et al . , 1993). On the other hand, there are some data indicating that a rapid and timely culture report can improve the clinical impact, achieve substantial savings in hospital costs and even decrease mortality (Doern et al., 1982; Trenholme et al., 1989; Doern et al., 1994). Thus, an optimal method for culture would be a totally automated system with a minimal delay in processing the samples all the way until reporting with no manual phases which interrupt the process.
The present status of bacteriological process automation can be described briefly as follows.
Automatic sample processing and culture inoculation are theoretically possible, at least for liquid or liquefied samples. Some devices for dilution of samples are available.
Culture follow-up automates are widely used for blood culture. Still, subcultures have to be done manually. Some attempts have been made for direct inoculation from the blood culture bottle to identification (Davis & Fuller, 1991), but even in this case mixed cultures cannot be handled. It seems that at least in blood culture plating of individual colonies is critical for proper susceptibility testing results (Travis & MacLowry, 1989).
There are no methods for automatic judging of the cultures and making subcultures from individual colonies.
Automated systems for identification are available. Most of those currently available require some preliminary classification of the bacteria (e.g. Gram-staining) , which has to be done manually. Analysis of membrane fatty acids (Eerola & Lehtonen, 1988) or sequencing of 16S ribosomal DNA (Jens- sen et al . , 1993) are methods which can be applied without such a previous classification.
Automated susceptibility testing systems are available. They, however, need a standardized inoculum, preferably from colonies grown on a solid medium.
The most critical steps for process automation are located in the beginning of the process, especially in the separation of the clones in the sample. Liquid cultures are cumbersome because they cannot cope with mixed cultures of different strains. Conventional agar plates are not very handy for automated processes. They have a limited shelf- life and are prone to contamination in automated handling. This is why the present inventor has attended to develop- ment of a new design for bacterial culture.
Description of the invention
The present invention provides a filter culture method which enables automated culturing of microbes. The method is called "Bactexpress" method. The method can be applied for various biological samples, e.g. body fluids, but also for water samples, or filterable food or environmental samples .
In the method a sample is first prepared to be filterable, if appropriate, i.e. in the case of a biological sample eukaryotic cells present in said sample are lysed. Then the sample obtained is filtered using a microbiological filter, and the filter is flushed with a liquid nutrient medium, which remains on the other side of the filter. The microbes which remain on the filter, are made to grow on it as if they grew on an agar plate, by establishing a gas pressure gradient using appropriate gases or gas mixtures. The medium should remain in contact with the filter. This can be accomplished e.g. by turning the filter around. The pressure gradient is used to prevent the medium from bleeding to the side of the filter where the microbes have been trapped. It is easy to change nutrient media and the gas mixtures during incubation. The method is suitable for automation as the culture method can be carried out using liquid flows, for which suitable technologies exist.
The culture method of the invention uses bacteriological filters (e.g. cellulose acetate) with pore sizes of 0.22 to 1.0 μm. Such filters are manufactured by e.g. Millipore. Most of the clinically relevant samples (blood, urine, ascites, pus, cerebrospinal fluid, synovial fluid) can be prepared for filtration by lysing the eukaryotic cells present therein. E.g. Zierdt (1982) has described a lysis process which can be used in the present method. Filtration of biological samples is described in various publications (e.g. Wallis & Melnick, 1985, Longoria et al . , 1987 and Bernhardt et al . , 1991), and any such filtration system can be used in the present method. After filtration of the sample, the filter is flushed with a liquid medium to remove growth inhibitors possibly present in a clinical sample. Then, a further amount of liquid medium is added and filtered until to the other side of the filter. After filtration the filter is turned around, and a gas pressure gradient is established leading a gas or a gas mixture to the filter from below upwards, thereby constructing a solid-liquid interface. In the appended Figure l pilot scale arrangement for this system is illustrated. This setup gives a growth environment which results in visible colonies similarly as on an agar plate. A similar type of idea of combining liquid and solid media was disclosed decades ago (Kanz, 1951) but without the filtration procedure for inoculation of the sample. It should also be noted that Kanz used cellophane which is quite inappropriate for filtration. Contamination of the liquid medium is easy to avoid because the liquid flows in one direction only through the filter. The liquid medium can easily be changed, even during incubation, if necessary. Different gas mixtures can be used for different atmospheric requirements of the microbes. The principle of the inventive method is illustrated in the appended Figure 2.
The now presented configuration would enable automation because control of the culture process is easy by regulating the flow of the liquid nutrient medium. Using solid culture media would necessitate very cumbersome robotics. The liquid flow serves for inoculation of the sample, con- struction of the "solid" culture medium as well as disinfection and removal of infectious material. Video technology could be used for the subsequent surveillance of the growth of the colonies, and gas chromatography or sequence analysis of ribosomal DNA would be useful for further auto- matic identification of the cultures.
Other applications for the culture method of the invention are e.g. construction of a microbiological culture method in field conditions from dry nutrient medium and water using the filter, as well as replacement of natural agar in microbiological culture research. Brief description of drawings
Fig. 1 Pilot scale arrangement for culture system according to the invention.
Fig. 2 The liquid nutrient broth and the test sample are first filtered through the filter; the bacteria remain on the side B. The filter is then turned around, and the nutrient broth on the side A acts as growth medium. Diffu- sion of the nutrient broth to side B and prevention of excessive moisture by a pressure gradient (0.01 to 0.5 bar) enable growth of visible and dispersed colonies as on agar plates.
Experimental
Filterability testing of blood samples
The experiments were carried out using blood culture samples . The blood samples were filterable in the given circumstances (see Wallis and Melnick, 1985) when detergents were added to a commercially available sample tube (Isolator™).
The microbes tested in pure cultures: Escherichia coll, Enterococcus faecalis , Haemophilus influ- enzae. Streptococcus pneυmoniae , Streptococcus miller 1, Streptococcus agalactiae, Candida albicans, Pseudomonas aeruginosa, Staphylococcus epidermidis, Pasteurella multo- cida, Bacteroides fragiliε
Example 1: Comparative tests - present system versus agar plate cultivation
Comparative tests using the present filter culture method and on the other hand transferring the filter onto a conventional agar plate were carried out with the above listed microbes. The agar plate method with filter is currently used e.g. in food laboratories. The parameters measured were 1) number of the colonies, 2) size of the colonies, and 3 ) existence of separate colonies. The variables were a) composition of the nutrient medium, b) incubation time and c) different types of membrane filters. The influence of antibiotics on the filters as well as changing of the nutrient medium during the incubation' were also studied.
Results
Results of the experiments carried out with different nutrient medium compositions are given in Table 1.
Table legend:
+: a successful test, i.e. good growth (+): a faint growth
-: an unsuccessful test, i.e. no growth; empty field: no experiment so far.
Abbreviations in Table 1 : BHI = Brain Heart Infusion (Difco)
FBS = Fetal Bovine Serum 5% (Finnzymes Oy) BLOOD = heated sheep blood, 5% NAD = a growth factor in blood (7.5 μg/ml ) HEMIN = a growth factor in blood (7.5 μg/ml )
The results given in Table 1 show that various bacteria having clinical importance can be successfully cultivated with the present "Bactexpress" system. However, the most fastidious species need medium supplements. Table 1
Example 2 : Comparative tests with Escherichia coli and Enterococcus faecalis
Comparative tests using the present filter culture method and on the other hand transferring the filter onto a conventional agar plate were carried out using Escherichia coli (ATCC 25922) and Enterococcus faecalis (ATCC 29212).
Conditions: Nutrient media: Brain Heart Infusion (BHI) Broth (Dif- co)
Brain Heart Infusion Agar (1.5% Bacto
Agar)
Temperature: 37 °C
Filter: Cellulose acetate membrane 0.45 μm
Variables: Pressure (air) 0.5 bar
0.3 bar
0.1 bar
0.05 bar Incubation time 14 h
21 h
Quantities measured: number of colonies size of colonies number of separate colonies
Six replications were used in both methods.
The results are given in Table 2.
Table 2 Comparison of Bactexpress and agar methods
According to the results obtained it seems that the lower pressure, the bigger size of the colonies. The lowest pressures used, i.e. 0.05 to O.l bar, are sufficient and are functioning best. The number and size .of the colonies using the Bactexpress method are smaller than the average number and size of the colonies using the conventional agar plate system. The inventive method can, however, be considered quite functional . Example 3: Seeking the optimum conditions for Streptococcus agalactiae
The optima of Bactexpress-method for a clinical strain of Streptococcus agalactiae (TY 659) were studied by varying the pressure and concentration of fetal bovine serum (FBS) in tryptic soya broth. The yield of colonies was compared to the yield of colonies on tryptic soya agar with 0.5 per cent FBS. The mean diameter of the colonies was measured from 10 individual colonies on filter. The number of colonies not confluent to adjacent colonies was counted and expressed as the percentage of the total number of colonies. Each combination of pressure and serum concentration was studied in five parallel filters. The results are shown in Tables 3, 4 and 5.
Table 3. Effect of the pressure and concentration of FBS on the yield of colonies of Streptococcus agalactiae in Bactexpress-method, per cent out of the colonies grown on tryptic soya agar with 0.5 per cent FBS.
Table 4. Effect of the pressure and concentration of FBS on the mean diameter of colonies of Streptococcus agalactiae in Bactexpress-method.
Table 5. Effect of the pressure and concentration of FBS on the percentage of non-confluent colonies of Streptococcus agalactiae in Bactexpress-method.
The results show that Bactexpress-method needs more serum supplement than agar culture to yield the same number of colonies. However, using pressure of 0.2 bar, and FBS concentration of 10 per cent, a good yield of mostly non- confluent colonies is obtained.
References
Bernhardt M, Pennell DR, Aimer LS, Schell RF. Detection of bacteria in blood by centrifugation and filtration. J. Clin. Microbiol. 1991; 29: 422-425.
Campo L, Mylotte JM. Use of microbiology reports by physicians in prescribing antimicrobial agents. Am. J. Med. Sci. 1988; 296: 392-398.
Davis TB, Fuller DD. Direct identification of bacterial isolates in blood cultures by using a DNA probe. J. Clin. Microbiol. 1991; 29: 2193-2196.
Doern GV, Scott DR, Rashad AL. Clinical impact of rapid antimicrobial susceptibility testing of blood culture isolates. Antimicrob. Agents Chemother 1982; 21: 1023-1024.
Doern GV, Vautour R, Gaudet M, Levy B. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J. Clin. Microbiol. 1994; 32: 1757-1762.
Eerola E, Lehtonen 0-P. Optimal data processing procedure for automatic bacterial identification by gas-liquid chro- matography of cellular fatty acids. J. Clin. Microbiol. 1988; 26: 1745-53.
Jenssen MA, Webster JA, Straus N. Rapid identification of bacteria on the basis of polymerase chain reaction-amplified ribosomal DNA spacer polymorphisms. Appl. Environ. Microbiol. 1993; 59: 945-952.
Jorgensen JH. Automation in clinical microbiology. CRC Press Inc. Boca Raton, Florida, 1987.
Kanz E. Das Flϋfe-Verfahren, eine neue Form von Membran- nahrbδden. Arch. Hyg. 1951; 140: 106-129.
Lehtonen 0-P, Rintala E, Eerola E. Poor value of routine susceptibility tests in guidance of antimicrobial therapy, (abstract) 7th Congress of European Society of Clinical Microbiology and Infectious Diseases, Seville, 1993.
Longoria CC, Gonzales GA. FiltraCheck-UTI, a rapid, disposable system for detection of bacteruria. J. Clin. Microbiol. 1987; 25: 926-928.
Rintala E, Kairisto V, Eerola E, Nikoskelainen J, Lehtonen 0-P. Antimicrobial therapy of septicemic patients in intensive care units before and after blood culture reporting. Scand. J. Infect. Dis. 1991; 23: 341-346.
Travis LB, MacLowry JD. Clinically significant differences in antibiograms of morphologic variants of blood culture isolates. Diagn. Microbiol. Infect. Dis. 1989; 12: 177-179. Trenholme GM, Kaplan RL, Karakusis PH, Stine T. Fuhrer J. Landau W, Levin S. Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates. J. Clin. Microbiol. 1989; 27: 1342-1345.
Wallis C, Melnick JL. Rapid, colorimetric method for the detection of microorganisms in blood culture. J. Clin. Microbiol.1985; 221 : 505-508.
Zierdt CH. Blood-lysing solution nontoxic to pathogenic bacteria. J. Clin. Microbiol. 1982; 15: 172-174.

Claims

Claims
1. A method for culturing microorganisms present in a sample, comprising a) filtering the sample through a microbiological filter, b) flushing the filter with a liquid nutrient medium, and c) establishing a gas pressure gradient for retaining contact between the filter and the liquid medium but enabling growth of separate colonies during the subsequent incubation.
2. The method according to claim 1, wherein, prior to step a) the sample is prepared to be filterable by lysing eukaryotic cells present in the sample.
3. The method according to claim 2, wherein the sample is a whole blood sample.
4. The method according to claim 2 , wherein the sample is synovial fluid, cerebrospinal fluid, ascites, or any other body liquid.
5. The method according to claim 1, wherein the pore size of the filter is 0.22 to 1.0 ╬╝m, and wherein a pressure of 0.01 to 0.5 bar is used.
6. The method according to claim 5 , wherein a pressure of 0.05 to 0.1 bar is used.
EP98950130A 1997-10-24 1998-10-23 Method for culturing microbiological samples in a gas pressure gradient Withdrawn EP1025202A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI974043A FI105044B (en) 1997-10-24 1997-10-24 Method for culturing microbiological samples
FI974043 1997-10-24
PCT/FI1998/000828 WO1999021960A1 (en) 1997-10-24 1998-10-23 Method for culturing microbiological samples in a gas pressure gradient

Publications (1)

Publication Number Publication Date
EP1025202A1 true EP1025202A1 (en) 2000-08-09

Family

ID=8549792

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98950130A Withdrawn EP1025202A1 (en) 1997-10-24 1998-10-23 Method for culturing microbiological samples in a gas pressure gradient

Country Status (3)

Country Link
EP (1) EP1025202A1 (en)
FI (1) FI105044B (en)
WO (1) WO1999021960A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101348827B (en) * 2008-07-29 2011-07-20 常俊山 Air planktonic bacteria detected by scrubbing method and special detecting bottle therefor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122581B1 (en) * 1983-04-15 1991-01-16 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Process for isolating bacteria in blood
US4839292B1 (en) * 1987-09-11 1994-09-13 Joseph G Cremonese Cell culture flask utilizing membrane barrier
GB9510634D0 (en) * 1995-05-25 1995-07-19 Sev Trent Water Ltd Filtration and culture methods and apparatus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9921960A1 *

Also Published As

Publication number Publication date
FI105044B (en) 2000-05-31
WO1999021960A1 (en) 1999-05-06
FI974043A0 (en) 1997-10-24
FI974043A (en) 1999-04-25

Similar Documents

Publication Publication Date Title
US9353397B2 (en) Microbiological systems and methods of fluid sample analysis
EP0285792B1 (en) A test set and a process for the determination of antibiotics in milk and a novel streptococcus thermophilus strain to be used therein
US8828682B2 (en) Methods and articles for detecting hemolytic microorganisms
IE69558B1 (en) Device and method for enhanced recovery and detection of microbial growth in the presence of antimicrobial substances
AU2021254655B2 (en) Microbiological growth media and methods of using the same
CN105586327B (en) A kind of source of people antalzyme protein purification process
CN110129406A (en) A kind of pseudomonas aeruginosa chromogenic culture medium and the method quickly detected using it
EP2377919B1 (en) Method for identification of bacteria of the genus Pectinatus and culture medium therefor
GB2037811A (en) Identification of Microorganisms
AU745791B2 (en) Method and apparatus for concentrating and searching of microbiological specimens
Ryan et al. Improved method for recovery of peritonitis-causing microorganisms from peritoneal dialysate
CA1212346A (en) Triphasic mycoplasmatales culture device and method
Bobbitt et al. The removal of bacteria from solutions by membrane filtration
EP1025202A1 (en) Method for culturing microbiological samples in a gas pressure gradient
EP0286434A2 (en) Method for the detection of bacteria and fungi
US5091307A (en) Procedure for the counting, detection and identification of mycoplasms in general and urinogenital mycoplasms in particular and a biological medium specially adapted to this effect
CN109988733A (en) A kind of streptococcus specific solid medium, preparation method and applications
Kozub et al. A practical blood culturing method employing dilution and filtration
Chan et al. Evaluation of lysis filtration as an adjunct to conventional blood culture.
Von Graevenitz Is there an optimal methodology for the microbiological analysis of effluent in CAPD peritonitis?
JP4779069B2 (en) Drug sensitivity test medium
ALFA et al. The co-existence of genital mycoplasmas and Neisseria gonorrhoeae isolated from the male urethra

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000504

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT CH DE DK ES FR GB IT LI NL SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 19991020

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040217